Skip to Content

Centene Corp

CNC: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$34.00JlxlrqqKdbrplb

Centene Earnings: 2024 Outlook Rises, as Individual Plan Strength Helps Offset Medicaid Pullback

Narrow-moat Centene exceeded expectations in the first quarter, including strength in its relatively high-margin individual plans, and the company raised its guidance for the full year. However, our bottom-line expectations were already in line with management's new outlook, and after making mild tweaks to our near-term assumptions, our $92 fair value estimate has not changed materially. Centene shares remain moderately undervalued.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of CNC so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center